Berlin December 4-5, 2015

Grand Hyatt Berlin

Scientific Committee:

K.-H. Kuck, Germany P. Della Bella, Italy G. Hindricks, Germany P. Jais, France

Meeting: 7th Euro VT/VF Meeting 2015

Date: December 4-5, 2015

Scientific Committee: K.-H. Kuck, Hamburg (DE), P. Della Bella, Milan (IT) G. Hindricks, Leipzig (DE), P. Jais, Bordeaux (FR)

Venue: Grand Hyatt Berlin Marlene-Dietrich-Platz 2, D-10785 Berlin Tel.: +49 (0) 30 25 53 12 34, Fax: +49 (0) 30 25 53 12 35 E-Mail: berlin.grand@hyatt.com, www.berlin.grand.hyatt.com

Language: The official conference language is English.

Registration fee: € 600,–

Registration fee includes: • Admission to the Scientific sessions • Congress Material • Coffee breaks & Lunch • Certificate of attendance

Online registration: www.euro-vtvf.eu

Organizer: Prof. Dr. Karl-Heinz Kuck Euro EP uG c/o Asklepios Klinik St. Georg Lohmühlenstraße 5, D-20099 Hamburg Tel.: +49 (0) 40 18 18-85 23 08, Fax: +49 (0) 40 18 18-85 44 44 E-Mail: k.kuck@asklepios.com, www.asklepios.com

Congress Agency:

wikonect GmbH Hagenauer Straße 53, D-65203 Wiesbaden Tel.: +49 (0) 611 20 48 09-0, Fax: +49 (0) 611 20 48 09-10 E-Mail: info@wikonect.de, www.wikonect.de

WWW.EURO-VTVF.EU

GENERAL INFORMATION

Partner:

The meeting is accredited by: The European Board of Accreditation in Cardiology

WWW.EURO-VTVF.EUDear colleagues, Dear friends,

New techniques like leadless pacing and subcutaneous defibril-lation, new treatment approaches like the modulation of the autonomous nervous system to impinge and prevent ventricular arrhythmias, successful strategies to reduce infection and other complications, stunning data and results from recent studies and last but not least creative food for thought to question traditional thinking and looking for new ways: these were the ingredients of a conference 2014 that has probably inspired all of us.

This great success encourages us even more to deve-lop the 7th Euro VT/VF Meeting 2015 to an even more powerful and exciting event. We would like to cordially invite you to attend our meeting on 4/5 December 2015 in Berlin.

The 7th Euro CT/VF Meeting in Berlin will once again be a forum bringing together the leading international colleagues in the field of ventricular arrhythmia that enables all of us to learn and benefit from the experiences and ideas of the best in their field.

We hope that this meeting will find your interest and we look forward to seeing you in Berlin.

K.-H. Kuck

P. Della Bella

G. Hindricks

P. Jais

PREFACE

2015

7TH EURO

2015

7TH EURO

08:00 – 08:05 Welcome day 2 and introduction P. Della Bella, Italy

08:05 – 08:50 Session 5

Outflow tract and papillary muscle ventricular tachycardia Chair: P. Della Bella, Italy; K.-H. Kuck, Germany

A new look on outflow tract cardiac anatomy (15’) B. Boukens, USA

Outflow tract VTs (15’) B. Lerman, USA

Inflow tract and Papillary muscle VTs (15’) F. Bogun, USA

08:50 – 10:50 Session 6

Targeting the substrate in specific VT entities Chair: A. Berruezo, Spain; V. Reddy, USA

The right ventricle in ARVC (15’+5’) C. Bisceglia, Italy

(post) Myocarditis (15’+5’) B. Berte, Switzerland

Sarkoidosis (15’+5’) A. Metzner, Germany

Channelopathies (15’+5’) J. Atie, Brazil

LVAD patients (15’+5’) F. Sacher, France

GUCH (15’+5’) K. Zeppenfeld, The Netherlands

10:50 – 11:00 Grab a coffee… in 10 min.

11:00 – 11:45 Session 7

Antiarrhythmic surgery for VT/VF: when and how? Chair: G. Hindricks, Germany; V. Reddy, USA

The surgeons view (15’) A. Fumero, Italy

The electrophysiologists view (15’) R. Tung, USA

Round table / audience discussion: planning, doing, avoiding (15’)

11:45 – 13:25 Session 8

ICD and VT Ablation: best enemies? Chair: K. Shivkumar, USA; K. Zeppenfeld, The Netherlands

Are ICD shock related to mortality – what´s the link? (15’+5’) V. Reddy, USA

Will catheter ablation reduce mortality? (15’+5’) R. Tung, USA

08:30 – 08:45 Welcome

Welcome to Euro VT/VF Meeting 2015 K.-H. Kuck, Germany

Why are we doing Euro VT/VF: scope of the program P. Della Bella, Italy

08:45 – 09:05 Special lecture

Setting the stage: The 2015 ESC guidelines (20’) C. Blomstroem, Sweden

09:05 – 10:35 Session 1

VT ablation in structural heart disease – when is the right time? Chair: C. DeChillou, France; F. Sacher, France

Why is timing really important? (15’) B. Dinov, Germany

“Always” try AA drugs before ablation (15’) G. Breithardt, Germany

“Always” avoid AA drugs and go directly to ablation (15’) P. Vergara, Italy

I always use image integration (15’) F. Sacher, France

I never use image integration (15’) T. Deneke, Germany

Round table / audience discussion: Timing of ablation – any impact on outcome (15’)

10:35 – 10:55 Grab a coffee and rest… 20 min.

10:55 – 12:55 Session 2

VT ablation in structural heart disease – planning the procedure, effective ablation and avoiding crashes Chair: P. Della Bella, Italy; J. Kautzner, Czech Republic

Pre-procedural imaging (15’) A. Berruezo, Spain

How to get best access? (15’) A. Arya, Germany

Activation and pace mapping to guide ablation (15’) C. De Chillou, France

De-channeling, homogenization and LAVAs (15’) A. Al Ahmad, USA

Techniques to enhance ablation effects: force sensing, novel electrodes & energies ... and alcohol (15’) F. Sacher, France

How to avoid crashes? (15’) F. Baratto, Italy

What´s the best end point? (15’) F. Ouyang, Germany

Round table / audience discussion: planning, doing, avoiding (15’)

12:55 – 13:55 Lunch

13:55 – 15:25 Session 3

VT ablation in structural heart disease – optimize post ablation management Chair: A. Berruezo, Spain; G. Hindricks, Germany

Amiodarone after ablation: start, continue or stop? (15’) D. Frankel, USA

Predicting recurrences: who is at special risk? (15’) W.H. Sauer, USA

NIPS to guide device programming after ablation (15’) T. Oloriz, Spain

Re-ablation: timing, strategy and limitations (15’) H. Kottkamp, Switzerland

When ablation fails: do we have bail outs? (15’) T. de Potter, Belgium

Round table / audience discussion: planning, doing, avoiding (15’)

15:25 – 15:45 Grab a coffee and rest… 20 min.

15:45 – 17:45 Session 4

Recurrent VT/VF in patients with advanced heart failure Chair: H. Kottkamp, Switzerland; S. Willems, Germany

Special lecture:

EHRA / HFA 2015 document of heart failure and arrhythmias (20’) N. Dagres, Greece

Drugs are important – not ablation (15’) D. Andresen, Germany

Challenger (10’) D. Bänsch, Germany

Revascularization / CTOs is helpful to cure VT (15’) A. Di Marco, Spain

Challenger (10’) B. Dinov, Germany

CRT exerts antiarrhythmic effects (15’) J. Steffel, Switzerland

Challenger (10’) S. Richter, Germany

LVADs before ablation are a reasonable option (15’) T. Deneke, Germany

Challenger (10’) K. Zeppenfeld, The Netherlands

17:45 – 18:00 Wrap up Day 1 and housekeeping notes G. Hindricks, Germany

FRIDAY SATURDAY

4 DECEMBER 2015

5 DECEMBER 2015

The never ending debate - ICD´s are mandatory after catheter ablation in structural heart disease:

Pro (10’+5’ rebuttal) M. O´Neil, United Kingdom

Con (10’+5’ rebuttal) P. Maury, France

Imaging in sudden cardiac death (15’) J.J. Bax, The Netherlands

Update on device innovation (subQ, Wearable, leadless) (15’) C. W. Israel, Germany

13:25 – 13:50 Grab a snack in 25 min.

13:50 – 14:50 Session 9

The future of VT ablation: challenges, strategies and trials Chair: F. Bogun, USA; G. Hindricks, Germany

Buring questions – cool answers (15’) J. Silberbauer, United Kingdom

The American perspective (15’) K. Shivkumar, USA

The European Perspective (15’) K.-H. Kuck, Germany

Round table / audience discussion: Outcome trails in VT ablation: how can we do better (15’)

14:50 – 16:20 Session 10 My biggest disaster – when VT ablation becomes a drama

A case from Hamburg (15’) K.-H. Kuck, Germany

A case from Leipzig (15’) G. Hindricks, Germany

A case from Rio (15’) J. Atie, Brazil

A case from Milano (15’) P. Della Bella, Italy

Round table / audience discussion: Make it safe -avoiding complications in VT ablation (30’)

16:20 – 16:30 End of story / farewell (10’) K.-H. Kuck & G. Hindricks, Germany

2015

7TH EURO